BE0414-5MG
| InVivoMAb anti-rat TCR ?/?
| 5 mg
| BioXCell
| in vivo ?/? T cell depletion, Flow cytometry
|
| Mouse
| Rat
| Solicitar Precio
| Solicitar
|
BP0297-50MG
| InVivoPlus human IgG1 isotype control
| 50 mg
| BioXCell
|
|
| Human
|
| Solicitar Precio
| Solicitar
|
BE0386-100MG
| InVivoMAb anti-human CD326 (EpCAM)
| 100 mg
| BioXCell
| Immunohistochemistry (paraffin), Immunofluorescenc
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
BP0016-2-50MG
| InVivoPlus anti-mouse CD40
| 50 mg
| BioXCell
| in vivo CD40 activation, in vitro B cell stimulati
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0385-1MG
| InVivoMAb anti-mouse DKK3
| 1 mg
| BioXCell
| in vivo DKK3 blocking, in vitro DKK3 blocking, Wes
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
BE0398-1MG
| InVivoMAb anti-mouse CD83
| 1 mg
| BioXCell
| in vivo CD83 engagement, in vitro CD83 blockade, F
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0402-25MG
| InVivoMAb anti-human GPC-2
| 25 mg
| BioXCell
| , ,
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
BP0273-50MG
| InVivoPlus anti-mouse PD-1 (CD279)
| 50 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling, in vitro
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BP0274-5MG
| InVivoPlus anti-mouse TIGIT
| 5 mg
| BioXCell
| in vivo TIGIT stimulation, Flow cytometry
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
BP0083-5MG
| InVivoPlus mouse IgG1 isotype control, unknown specificity
| 5 mg
| BioXCell
|
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
BE0388-25MG
| InVivoMAb anti-human CD71 (TfR1)
| 25 mg
| BioXCell
| Immunohistochemistry (frozen)
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
BE0409-50MG
| InVivoMAb anti-human BRCA1
| 50 mg
| BioXCell
| , ,
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
BE0390-5MG
| InVivoMAb anti-canine PD-L1 (B7-H1)
| 5 mg
| BioXCell
| in vitro PD-L1 blockade, Functional assays, Wester
|
| Dog
| Dog
| Solicitar Precio
| Solicitar
|
BE0396-5MG
| InVivoMAb anti-human/mouse GRP78
| 5 mg
| BioXCell
| in vivo GRP78 blockade, in vitro GRP78 blockade, W
|
| Mouse
| Human, Mouse
| Solicitar Precio
| Solicitar
|
BE0412-100MG
| InVivoMAb anti-human GPC3
| 100 mg
| BioXCell
| , ,
|
| Human
|
| Solicitar Precio
| Solicitar
|
BP0075-1-25MG
| InVivoPlus anti-mouse Ly6G
| 25 mg
| BioXCell
| in vivo neutrophil depletion, in vivo MDSC depleti
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BP0297-5MG
| InVivoPlus human IgG1 isotype control
| 5 mg
| BioXCell
|
|
| Human
|
| Solicitar Precio
| Solicitar
|
BP0290-100MG
| InVivoPlus rat IgG1 isotype control, anti-trinitrophenol
| 100 mg
| BioXCell
|
|
| Rat
| Rat
| Solicitar Precio
| Solicitar
|
BP0033-2-25MG
| InVivoPlus anti-mouse PD-1 (CD279)
| 25 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling, in vitro
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
BE0387-25MG
| InVivoMAb anti-mouse/human phosphorylated PD-1 (CD279)
| 25 mg
| BioXCell
| Western Blot, Flow Cytometry
|
| Mouse
| Human, Mouse
| Solicitar Precio
| Solicitar
|
BE0411-50MG
| InVivoMAb anti-human GC1q R (C1QBP)
| 50 mg
| BioXCell
| , ,
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
BP0090-5MG
| InVivoPlus rat IgG2b isotype control, anti-keyhole limpet hemocyanin
| 5 mg
| BioXCell
|
|
| Rat
|
| Solicitar Precio
| Solicitar
|
BE0412-1MG
| InVivoMAb anti-human GPC3
| 1 mg
| BioXCell
| , ,
|
| Human
|
| Solicitar Precio
| Solicitar
|
BP0115-100MG
| InVivoPlus anti-mouse TIM-3 (CD366)
| 100 mg
| BioXCell
| in vivo TIM-3 neutralization, in vitro TIM-3 block
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0414-50MG
| InVivoMAb anti-rat TCR ?/?
| 50 mg
| BioXCell
| in vivo ?/? T cell depletion, Flow cytometry
|
| Mouse
| Rat
| Solicitar Precio
| Solicitar
|
BP0174-5MG
| InVivoPlus anti-mouse LAG-3
| 5 mg
| BioXCell
| in vivo LAG-3 neutralization, in vitro LAG-3 neutr
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BP0004-1-5MG
| InVivoPlus anti-mouse CD8?
| 5 mg
| BioXCell
| in vivo CD8+ T cell depletion, Immunofluorescence,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0379-25MG
| InVivoMAb anti-mouse TSLP
| 25 mg
| BioXCell
| in vivo TSLP neutralization, in vitro TSLP neutral
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0398-25MG
| InVivoMAb anti-mouse CD83
| 25 mg
| BioXCell
| in vivo CD83 engagement, in vitro CD83 blockade, F
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BP0308-100MG
| InVivoPlus anti-rat CD4
| 100 mg
| BioXCell
| in vivo CD4+ T cell depletion, Flow cytometry
|
| Mouse
| Rat
| Solicitar Precio
| Solicitar
|
BE0385-50MG
| InVivoMAb anti-mouse DKK3
| 50 mg
| BioXCell
| in vivo DKK3 blocking, in vitro DKK3 blocking, Wes
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
BE0409-100MG
| InVivoMAb anti-human BRCA1
| 100 mg
| BioXCell
| , ,
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
BP0060-5MG
| InVivoPlus anti-mouse VEGFR-2
| 5 mg
| BioXCell
| in vivo blocking of VEGF/VEGFR-2 signaling, in vit
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BP0004-1-25MG
| InVivoPlus anti-mouse CD8?
| 25 mg
| BioXCell
| in vivo CD8+ T cell depletion, Immunofluorescence,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BP0031-5MG
| InVivoPlus anti-mouse OX40 (CD134)
| 5 mg
| BioXCell
| in vivo OX40 activation, in vitro OX40 activation,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0392-5MG
| InVivoMAb anti-mouse myeloperoxidase (MPO)
| 5 mg
| BioXCell
| in vivo administration, in vitro administration, I
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
BP0273-5MG
| InVivoPlus anti-mouse PD-1 (CD279)
| 5 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling, in vitro
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BP0241-100MG
| InVivoPlus anti-mouse IFNAR-1
| 100 mg
| BioXCell
| in vivo IFNAR-1 blockade, in vitro IFNAR-1 blockad
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
BP0060-50MG
| InVivoPlus anti-mouse VEGFR-2
| 50 mg
| BioXCell
| in vivo blocking of VEGF/VEGFR-2 signaling, in vit
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0397-25MG
| InVivoMAb anti-human/mouse GRP78
| 25 mg
| BioXCell
| in vivo GRP78 targeting, in vitro GRP78 targeting,
|
| Mouse
| Human, Mouse
| Solicitar Precio
| Solicitar
|
BP0083-50MG
| InVivoPlus mouse IgG1 isotype control, unknown specificity
| 50 mg
| BioXCell
|
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
BP0063-25MG
| InVivoPlus anti-mouse GITR
| 25 mg
| BioXCell
| in vivo GITR stimulation
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BP0051-5MG
| InVivoPlus anti-mouse IL-12 p40
| 5 mg
| BioXCell
| in vivo IL-12p40 neutralization, p40 affinity chro
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BP0079-25MG
| InVivoPlus anti-human MHC Class I (HLA-A, HLA-B, HLA-C)
| 25 mg
| BioXCell
| Functional assays
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
BE0398-100MG
| InVivoMAb anti-mouse CD83
| 100 mg
| BioXCell
| in vivo CD83 engagement, in vitro CD83 blockade, F
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BP0146-25MG
| InVivoPlus anti-mouse PD-1 (CD279)
| 25 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BP0213-5MG
| InVivoPlus anti-mouse CSF1R (CD115)
| 5 mg
| BioXCell
| in vivo macrophage depletion, in vitro CSF1R neutr
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BP0239-100MG
| InVivoPlus anti-mouse 4-1BB (CD137)
| 100 mg
| BioXCell
| in vivo 4-1BB stimulation, in vitro 4-1BB stimulat
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0394-5MG
| InVivoMAb anti-mouse IL-25
| 5 mg
| BioXCell
| in vivo IL-25 neutralization
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
BE0411-25MG
| InVivoMAb anti-human GC1q R (C1QBP)
| 25 mg
| BioXCell
| , ,
|
| Mouse
|
| Solicitar Precio
| Solicitar
|